News

  • 2016 Yankee Dental Congress

    Izun had a big presence at the Yankee  with over 500 people visiting the booth. A lot of new faces but even more impressive- a lot of the dentists and hygienists who ordered at the GNDYM were pleased with the products efficacy and re-ordered. We are getting lots of specialty offices using the Izun products

    Read More February 2, 2016
  • PerioPatch-Box-izunpharma

    PerioPatch – An Incredible Product For Treating Periodontal Disease

    All those people who have suffered from periodontal diseases or gingivitis at some point in their lives would never like to face such diseases again, considering the fact that one has to go through a lot of pain and difficulties. In the simplest way possible, periodontal diseases can be described as the infections and inflammations

    Read More January 26, 2016
  • Podcast- “From the Mid West to the Middle East”

    Our executive chairman, Dr. Billy Levine, was recently interviewed for a popular podcast called “From the Mid West to the Middle East”. Hear some fascinating facts about Izun Pharma.    

    Read More January 20, 2016
  • Periodontal-Diseases-Izunpharma

    Periodontal Diseases And Different Treatment Options

    Bleeding gums can be quite common when brushing and flossing, and none of us are usually bothered to figure out what makes them bleed. For most of us, it’s a usual problem that’s faced by all most everyone around us and probably that’s the reason we start ignoring it. Do you think it’s right to

    Read More January 20, 2016
  • Dental-Meeting-at-NY-Banner

    Izun at the Greater New York Dental Meeting

                        Izun Oral Care will be at the Greater New York Dental Meeting on Sunday November, 29! Stop by booth 1628! Below is the address: Jacob Javits Center 655 W. 34th St New York, NY 10001

    Read More November 25, 2015
  • PerioPatch-Box-izunpharma

    Izun Announces Breakthrough in Treatment of Peri-Implantitis affecting Dental Implants

    Company Representatives will be available to discuss results at Greater New York Dental Meeting, 30-Nov-2015 – 02-Dec-2015 Izun Oral Care (www.izunoralcare.com) a division of Izun Pharmaceuticals announced positive clinical data in a post-approval trial evaluating PerioPatch in the treatment of peri-implantitis. Peri-implantitis and peri-implant mucositis affect up to 48% of all implants placed. These conditions

    Read More November 25, 2015
  • Diabetic-Foot-Ulcers

    Izun Pharmaceuticals Announces Positive Results From Phase 2 Randomized Trial in Diabetic Foot Ulcers

    Company Plans to Meet with FDA to Discuss Filing Strategy for Approval Izun Pharmaceuticals Corporation, a clinical stage company focused on developing high efficacy products based on botanical sources announced today that it has successfully completed a multicenter randomized, controlled trial comparing Curasite™, a topical pharmaceutical gel, to a matching active hydrogel placebo to treat

    Read More October 13, 2015
  • Jack_Talley-resize

    Izun Pharmaceuticals Corp Appoints Jack Talley as Chief Executive Officer

    Izun Pharmaceuticals Corporation, a clinical stage company focused on developing high efficacy products based on compounds derived from botanical sources announced today that it has appointed Jack Talley as its Chief Executive Officer. Mr. Talley brings over 30 years of relevant experience in the pharmaceutical industry, fifteen of which were as CEO in emerging pharmaceutical

    Read More July 22, 2015
  • CannRx Technology Partner Receives ISO 17025 Certification for Its Laboratory

    CannRx Technology, Inc. (“CannRx”, www.cannrx.com), a privately-held Delaware corporation whose mission is to develop high quality pharmaceutical products from cannabis by leveraging its patented technology, announced today that its partner Izun Pharmaceuticals has been awarded ISO 17025 certification for the analysis  of cannabis and cannabis-based products. The certification of Izun represents the first laboratory in

    Read More April 22, 2015
  • PerioPatch-Box-izunpharma

    Izun Pharmaceuticals Reports Positive Data for Oral PerioPatch® in the Treatment of Periodontitis

    PerioPatch®, a novel oral trans-mucosal patch system that reduces inflammation and promotes tissue repair, has been shown to significantly reduce pocket depth (PD) and to generate an increase in attachment level (AL) in patients with advanced periodontal disease Izun Pharmaceuticals Corporation an emerging specialty pharmaceutical company in New York which focuses on developing best in

    Read More February 24, 2015